700 lupus patients join european study to unlock secrets of early disease
NCT ID NCT07209540
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This study will follow about 700 adults recently diagnosed with lupus across Europe for up to 5 years. Researchers want to see how many patients reach low disease activity or remission in the first year, and find markers in blood or urine that predict how the disease will progress. Participants continue their normal care and attend extra study visits to share symptoms, treatment details, and samples. The goal is to better understand lupus from the start and improve future treatment strategies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.